Gene · 9101
Papers1,448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,448
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Male-biased Cyp17a2 orchestrates antiviral sexual dimorphism in fish via STING stabilization and viral protein degradation. | Elife | 2026 | 41705328 | PubTator, text mining | PubMed |
| Molecular biology of pituitary neuroendocrine tumors. | J Neurooncol | 2026 | 41639477 | PubTator, text mining | PubMed |
| Plasma Proteomic Profile of Chemotherapy-Induced Severe Neutropenia: A Pilot Discovery Phase Study. | FASEB J | 2026 | 41622794 | PubTator, text mining | PubMed |
| Trim15 stabilizes VDAC3 via ubiquitination to suppress autophagy and enhance chemosensitivity in hypopharyngeal squamous cell carcinoma. | Cell Death Discov | 2026 | 41617671 | PubTator, text mining | PubMed |
| TGF-β in tumor development and progression: mechanisms and therapeutics. | Mol Biomed | 2026 | 41615651 | PubTator, text mining | PubMed |
| A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma. | Orphanet J Rare Dis | 2026 | 41612354 | PubTator, text mining | PubMed |
| Endothelial USP8 is essential for angiogenesis. | Angiogenesis | 2026 | 41606310 | PubTator, text mining | PubMed |
| Targeted recruitment of USP15 enhances CTLA4 surface levels and restricts its degradation. | Life Sci Alliance | 2026 | 41571434 | PubTator, text mining | PubMed |
| Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression. | Cell Death Dis | 2026 | 41565619 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| USP8-mediated mitochondrial regulation in osteoclasts is essential for skeletal development. | Cell Mol Life Sci | 2026 | 41537972 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Peptidase 8 Mediates Angiotensin-II-Induced Smooth Muscle Cell Phenotypic Transformation during Hypertension via Regulating LRRC8A. | Am J Hypertens | 2026 | 41499430 | PubTator, text mining | PubMed |
| Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review. | Cancer Treat Res Commun | 2026 | 41496269 | PubTator, text mining | PubMed |
| Regulation of autophagy-Ferroptosis crosstalk by the SLC7A11-GPX4 axis during sperm capacitation. | Theriogenology | 2026 | 41483535 | PubTator, text mining | PubMed |
| USP8-EIF2S1 signaling enhances CML cell survival under TKI-induced stress. | FEBS J | 2026 | 41454439 | PubTator, text mining | PubMed |
| USP8-Rearranged Mesenchymal Tumors With Myofibroblastic Phenotype: A Comprehensive Clinicopathologic, Genetic, and Epigenetic Characterization. | Mod Pathol | 2026 | 41380847 | PubTator, text mining | PubMed |
| Comment on "The USP8/CEP55/CHMP6 Axis Orchestrates Triple-Negative Breast Cancer Progression by Regulating Ferroptosis and Macrophage M2 Polarization". | Clin Breast Cancer | 2026 | 41270355 | PubTator, text mining | PubMed |
| The deubiquitinating enzyme USP8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF2S1 protein. | FEBS J | 2026 | 41147744 | PubTator, text mining | PubMed |
| The USP8/CEP55/CHMP6 Axis Orchestrates Triple-Negative Breast Cancer Progression by Regulating Ferroptosis and Macrophage M2 Polarization. | Clin Breast Cancer | 2026 | 40925844 | PubTator, text mining | PubMed |
| Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma. | J Hepatol | 2026 | 40759200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9101/papers?page=3